Under a deal announced Wednesday, the Kansas-based Sisters of Charity of Leavenworth, a Roman Catholic-affiliated health system, will control three Colorado hospitals, the Denver Post reports. The move would require the hospitals to follow Catholic directives regarding health care, and advocates are concerned about access to emergency contraception, abortion and other services that the Catholic Church opposes. The deal between Sisters of Charity and its co-sponsor, Community First Foundation, includes the sale of Exempla Lutheran in Wheat Ridge, Colo., and Good Samaritan Medical Center in Lafayette, Colo., both of which are owned by Exempla.
When it comes to potential mates, women may be as complicated as men claim they are, according to psychologists. "We have found that women evaluate facial attractiveness on two levels -- a sexual level, based on specific facial features like the jawbone, cheekbone and lips, and a nonsexual level based on overall aesthetics, " said Robert G. Franklin, graduate student in psychology working with Reginald Adams, assistant professor of psychology and neurology, Penn State. "At the most basic sexual level, attractiveness represents a quality that should increase reproductive potential, like fertility or health." On the nonsexual side, attractiveness can be perceived on the whole, where brains judge beauty based on the sum of the parts they see.
"To be sure, no group is doing well under our network of private insurers, " but "women fare particularly badly in terms of health, being more likely than men to leave a prescription unfilled; forgo seeing a needed specialist; and skip a medical test, treatment or follow-up, " author Sharon Lerner writes in an opinion piece in The Nation. "Despite the fact that they skimp on their care to cut costs, three in five women are still unable to pay medical bills, " Lerner continues. She adds that such statistics "make it surprising that men and women support health reform in almost equal numbers" -- 38% and 40%, respectively -- according to a recent Kaiser Family Foundation poll.
Bionovo To Present Positive Results From Phase 2 Trial Of Menerba For Vasomotor Symptoms To The International Community
Bionovo, Inc. (Nasdaq: BNVI) announced it will be presenting the positive results from the phase 2 clinical trial of their lead drug candidate for postmenopausal symptoms, Menerba, to the international community at the 8th Annual European Society for Gynecology (EGS) in Rome, Italy. The phase 2 clinical trial was designed to evaluate the safety and efficacy of two doses of Menerba versus placebo. The trial was a randomized, double-blinded, placebo-controlled study that enrolled 217 healthy postmenopausal women reporting moderate to severe hot flashes. Highlights from the trial include: -- After 12 weeks of treatment, there was a statistically significant decrease in frequency of all hot flashes in the higher dose of Menerba (p=0.
The New York Times examines how "[a] set of proposed international sex education guidelines aimed at reducing H.I.V. infections among young people" and unplanned pregnancies, based on "more than 80 studies of sex education, " has received some criticism. The release of the final guidelines, originally scheduled for next week by the United Nations Educational, Scientific and Cultural Organization (UNESCO), has been delayed. They would have been "distributed to education ministries, school systems and teachers around the world to help guide teachers in what to teach young people about their bodies, sex, relationships and sexually transmitted diseases, " the newspaper writes (Erlanger, 9/2).
The United Nations Population Fund (UNFPA) on Tuesday "appealed for the world to contribute more to improve women's health and access to contraception, " Agence France-Presse reports. Thoraya Ahmed Obaid, director of UNFPA, said it would cost $23 billion per year, which is an amount equal to "less than 10 days of the world's military spending, " to prevent "women from having unintended pregnancies and dying in childbirth." She was speaking at the start of a global forum on sexual and reproductive health, which assesses progress towards the goal of reducing the 500, 000 women that die annually in pregnancy or childbirth. Since 1994, when UNFPA started tracking its progress, "there have been successes, everything is not gloomy and dark, " according to Obaid, who said that a larger number of women now use contraception.